Blagosklonny goes on to write that even though rapamycin may reverse some manifestations of aging, it is more effective at slowing down aging than reversing it. Thus, rapamycin could be most effective ...

Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. Rapamycin is approved to treat renal cancer ...

Fifth issued patent in the U.S. for QTORIN™ rapamycin with anticipated patent life extending into 2038 QTORIN™ rapamycin has ...

Chronic lymphocytic leukemia (CLL) cell–derived exosomes demonstrated the ability to alter healthy donor cell function and ...

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the presentation of its investigational therapy QTORIN™ ...

Along with rapamycin, "researchers are also working on other drugs that may work in similar ways, and there's a push for new ...

Rapamycin is used to prevent graft rejection in transplant recipients based on its ability to suppress T-cell proliferation. The drug blocks the activity of a protein known as mammalian target of ...

Palvella Therapeutics (PVLA) announced QTORIN rapamycin 3.9% anhydrous gel for the treatment of microcystic lymphatic malformations was ...

Recent Research and Development Highlights The next target clinical indication for QTORIN™ rapamycin is anticipated in the second half of 2025. The expansion of QTORIN™ rapamycin into additional ...

Bryan Johnson, a billionaire tech entrepreneur, attempted to reverse his aging using rapamycin. He experienced mouth ulcers, slow-healing wounds, cholesterol abnormalities, and a spike in resting ...